Peroxisomal Disorders
The Peroxisomal Disorders session will be an overview of XALD (including NBS, monitoring, BMT, and Lorenzo's Oil), ZSD/PBD, RCDP, Adult Refsum.
Commercial Supporter
This educational activity is supported by an educational grant from Ultragenyx.
Learning Objectives
- Recognize the phenotype of genetic diseases caused by peroxisomal dysfunction.
- Identify patterns of metabolic abnormalities associated with genetic disorders of the peroxisome.
Guest Faculty
Hilary Vernon, MD
Johns Hopkins University
Disclosures
Hilary Vernon, MD, speaker for this session, is on the advisory board and has received clinical trial funding from Stealth Biotheraeutics, has received research funding from VectivBio and is a consultant for NeuroGene.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Medical
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance